High-Fat Diet Enhances Platelet Activation and Is Associated with Proprotein Convertase Subtilisin Kexin 9: An Animal Study. [PDF]
Saputri FC+9 more
europepmc +1 more source
Nonalcoholic Fatty Liver Disease Risk and Proprotein Convertase Subtilisin Kexin 9 in Familial Hypercholesterolemia Under Statin Treatment. [PDF]
Hamasaki M, Sakane N, Kotani K.
europepmc +1 more source
Retraction Note: Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection. [PDF]
Muzammil K+7 more
europepmc +1 more source
Effectiveness of proprotein convertase subtilisin/kexin type 9 inhibitors in managing hypercholesterolemia post-statin-associated immune-mediated necrotizing myopathy: report of five cases and literature review. [PDF]
Yerolatsite M+7 more
europepmc +1 more source
Potential Role of Proprotein Convertase SKI-1 in the Mineralization of Primary Bone [PDF]
Jeff P. Gorski+5 more
openalex +1 more source
Anti-inflammatory effects of proprotein convertase subtilisin/kexin 9 inhibitor therapy in the early phase of acute myocardial infarction. [PDF]
Shimizu T+12 more
europepmc +1 more source
The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis [PDF]
Seyed Ali Mousavi+2 more
openalex +1 more source
Proprotein Convertase Subtilisin Kexin 9 Inhibitor in Severe Sepsis and Septic Shock Patients in a Phase II Prospective Cohort Study-Preliminary Results. [PDF]
Rosman Z+7 more
europepmc +1 more source